跳至主要内容
临床试验/CTRI/2020/03/024326
CTRI/2020/03/024326已完成未知

A randomized double blind trial comparing three dosage schedules of itraconazole for the treatment of tinea corporis and cruris.

none0 个研究点目标入组 149 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
149

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 180 consenting adult patients with a diagnosis of Tinea cruris and/or corporis, on clinical examination with confirmation by KOH microscopy, who would require systemic treatment as per the assessment of the examining physician.

排除标准

  • a) Those on any regular systemic drug or with any pre-existing systemic disease.
  • b) Those with history of drug induced hepatotoxicity or ventricular dysfunction.
  • c) Those with deranged baseline liver function tests.
  • d) Those with a history of a hypersensitivity reaction to itraconazole before.
  • e) Pregnant and lactating females.

研究者

发起方
none

相似试验

已完成
不适用
Comparison of two medicines to check their effects on pain after repair of lower jaw breakage.
CTRI/2018/02/012260SDM College of Dental Sciences and Hospital100
进行中(未招募)
1 期
oradrenaline plus placebo vs noradrenaline plus terlipressin for thetreatment of septic shockMedDRA version: 20.0Level: LLTClassification code: 10040089Term: Septicemia Class: 10021881MedDRA version: 23.1Level: PTClassification code: 10040070Term: Septic shock Class: 100000004862Septic Shock
CTIS2024-514149-12-00Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla152
进行中(未招募)
1 期
oradrenaline plus placebo vs noradrenaline plus terlipressin for the treatment of septic shock
EUCTR2020-005756-37-ESFundación Pública Andaluza para la Gestión de la152
招募中
3 期
Effect of prophylactic azithromycin on chest infections in children with neurological and neuromuscular impairmenteurological impairmentNeurological impairmentRespiratory - Other respiratory disorders / diseasesNeurological - Other neurological disordersLower respiratory tract infection
ACTRN12621001486819Menzies School of Health Research94
已完成
不适用
Study to compare the treatment effects of Ginkgo biloba extract EGb 761® and Pentoxifylline in patients who suffer from tinnitus for more than three months and from psychological and social problems caused by the tinnitusChronic or subchronic tinnitusEar, Nose and ThroatTinnitus
ISRCTN68772788Dr. Willmar Schwabe GmbH & Co. KG (Germany)200